4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-005981
Global President TAVR & Surg sold 8,950 shares at $75.23 ($673,268)
- Global President TAVR & Surg acquired 8,950 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wood Larry L · Global President TAVR & Surg
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,950 | $59.26 | $530,347 | 215,850.39 | D |
| 2025-06-16 | Sale : show line 2 in the form 10b5-1 | −8,950 | $75.23 | $673,268 | 206,900.39 | D |
| Open-market sales · 8,950 sh · avg $75.23 · $673,268 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-16 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −8,950 | 44,750 | D |
Loading xslF345X05/doc4.xml…